Latest papers

Achieving full eradication of rinderpest in Africa.

A model of lineage-1 and lineage-2 rinderpest virus transmission in pastoral areas of East Africa.

A role for virus promoters in determining the pathogenesis of Rinderpest virus in cattle.

The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes.

Recombinant DNA technology for producing new rinderpest virus vaccines.

Ex-ante economic analysis of animal disease surveillance.

Rinderpest virus phosphoprotein gene is a major determinant of species-specific pathogenicity.

Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model.

Pathological and immunohistochemical study of experimental peste des petits ruminants virus infection in goats.

Experience with eradicating rinderpest by vaccination.

Detection of rinderpest virus using N-protein monoclonal antibodies.

Rinderpest surveillance performance monitoring using quantifiable indicators.

Monoclonal antibody-based competitive ELISA for simultaneous detection of rinderpest virus and peste des petits ruminants virus antibodies.

Use of participatory epidemiology in studies of the persistence of lineage 2 rinderpest virus in East Africa.

Rinderpest.

Epidemiological assessment of rinderpest surveillance and control in Uganda between 1990 and 1998.

Inexpensive vaccines and rapid diagnostic kits tailor-made for the global eradication of rinderpest, and technology transfer to Africa and Asia.

Development of new generation rinderpest vaccines.

Suitability of currently available vaccines for controlling the major transboundary diseases that afflict sub-Saharan Africa.

Rinderpest.